140 related articles for article (PubMed ID: 9951404)
21. Quantitative structure-activity relationships. Fujita-Ban analysis of beta-adrenergic blocking activity of 1-phenoxy-3-([(substituted amido)alkyl]amino)-2-propanols.
Gombar V
Arzneimittelforschung; 1986 Jul; 36(7):1014-8. PubMed ID: 2876713
[TBL] [Abstract][Full Text] [Related]
22. [On the synthesis of compounds with beta-adrenergic activity (author's transl)].
Lehmann D; Eckardt R; Faust G; Fiedler W
Pharmazie; 1980; 34(5-6):278-84. PubMed ID: 6106206
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and bovine beta 3-adrenergic agonistic activities of a novel series of aryloxypropanolamines.
el Hadri A; Nicolle E; Guillaume MC; Leclerc G; Pietri-Rouxel F; Strosberg AD; Archimbault P
Pharmazie; 2001 Jul; 56(7):517-22. PubMed ID: 11487967
[TBL] [Abstract][Full Text] [Related]
24. Modifications to the N-terminus but not the C-terminus of calcitonin gene-related peptide(8-37) produce antagonists with increased affinity.
Smith DD; Saha S; Fang G; Schaffert C; Waugh DJ; Zeng W; Toth G; Hulce M; Abel PW
J Med Chem; 2003 Jun; 46(12):2427-35. PubMed ID: 12773046
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (II).
Khouili M; Guillaumet G; Coudert G; Pujol MD
Farmaco; 1996 Mar; 51(3):185-8. PubMed ID: 8688140
[TBL] [Abstract][Full Text] [Related]
26. Cardioselectivity of beta-adrenoceptor blocking agents 1. 1-[(4-Hydroxyphenethyl)amino]-3-(aryloxy)propan-2-ols.
Rzeszotarski WJ; Gibson RE; Eckelman WC; Reba RC
J Med Chem; 1979 Jun; 22(6):735-7. PubMed ID: 37339
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
[TBL] [Abstract][Full Text] [Related]
28. Facile radiosynthesis of fluorine-18 labeled beta-blockers. Synthesis, radiolabeling, and ex vivo biodistribution of [18F]-(2S and 2R)-1-(1-fluoropropan-2-ylamino)-3-(m-tolyloxy)propan-2-ol.
Stephenson KA; Wilson AA; Meyer JH; Houle S; Vasdev N
J Med Chem; 2008 Aug; 51(16):5093-100. PubMed ID: 18656910
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and preliminary evaluation of [(18)F]-fluoro-(2S)-Exaprolol for imaging cerebral beta-adrenergic receptors with PET.
Stephenson KA; van Oosten EM; Wilson AA; Meyer JH; Houle S; Vasdev N
Neurochem Int; 2008 Nov; 53(5):173-9. PubMed ID: 18675864
[TBL] [Abstract][Full Text] [Related]
30. [beta-Adrenergic receptor blockers--a group of chiral drugs: different effects of each enantiomer].
Cizmáriková R
Ceska Slov Farm; 2002 May; 51(3):121-8. PubMed ID: 12058352
[TBL] [Abstract][Full Text] [Related]
31. HPLC separation of enantiomers of some potential beta-blockers of the aryloxyaminopropanol type using macrocyclic antibiotic chiral stationary phases. Studies of the mechanism of enantioseparation, Part XI.
Hrobonová K; Lehotay J; Cizmáriková R
Pharmazie; 2005 Dec; 60(12):888-91. PubMed ID: 16398262
[TBL] [Abstract][Full Text] [Related]
32. Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans.
Mehvar R; Brocks DR
J Pharm Pharm Sci; 2001; 4(2):185-200. PubMed ID: 11466176
[TBL] [Abstract][Full Text] [Related]
33. [The beta-adrenolytic activity of new arylmethyloxypropanolamine analogs of dioxadilol].
Baziard-Mouysset G; Ane-Margail M; Stigliani JL; Payard M; Verscheure Y; Tisne-Versailles J
J Pharm Belg; 1994; 49(2):126-32. PubMed ID: 7913492
[TBL] [Abstract][Full Text] [Related]
34. Modeling, design, chiral aspects and role of para-substituents in aryloxypropranolamine based beta-blockers.
Nandel FS; Dhaliwal RK; Singh B
Indian J Biochem Biophys; 1999 Feb; 36(1):29-35. PubMed ID: 10549157
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological evaluation of ocular beta-adrenoceptors in rabbit by tissue segment binding method.
Horinouchi T; Morishima S; Tanaka Y; Koike K; Miwa S; Muramatsu I
Life Sci; 2009 Jan; 84(5-6):181-7. PubMed ID: 19087880
[TBL] [Abstract][Full Text] [Related]
36. Binding of agonists and antagonists to beta-adrenergic receptor.
Miklavc A; Kocjan D; Hadzi D; Mavri J; Koller J
Prog Clin Biol Res; 1989; 291():275-80. PubMed ID: 2567011
[No Abstract] [Full Text] [Related]
37. Adrenoceptor blocking agents. Compounds related to metoprolol.
Lövgren K; Hedberg A; Nilsson JL
J Med Chem; 1981 Apr; 24(4):451-4. PubMed ID: 6115060
[TBL] [Abstract][Full Text] [Related]
38. Novel hybrids of natural isochroman-4-one bearing N-substituted isopropanolamine as potential antihypertensive candidates.
Bai R; Huang X; Yang X; Hong W; Tang Y; Yao H; Jiang J; Liu J; Shen M; Wu X; Xu J
Bioorg Med Chem; 2013 May; 21(9):2495-502. PubMed ID: 23538234
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of novel (aryloxy)propanolamines and related compounds possessing both class II and class III antiarrhythmic activity.
Lis R; Morgan TK; Marisca AJ; Gomez RP; Lind JM; Davey DD; Phillips GB; Sullivan ME
J Med Chem; 1990 Oct; 33(10):2883-91. PubMed ID: 1976812
[TBL] [Abstract][Full Text] [Related]
40. [Synthesis of aryloxypropanolamines with chromone or coumarin structures. Study of beta-blocking activity].
Gesquière JC; Dhaisne JM; Marcinal-Lefebvre A; Bar D; Vincent A; Dupuis B
Ann Pharm Fr; 1982 Sep; 40(3):251-7. PubMed ID: 6129826
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
